Our online catalog with more than 190 individual allergens, 16 mixtures and 23 finished medications will assist you with specific immune therapies for your patients. One click will take you from the allergen to the appropriate preparation.

In more than 100 contributions on diagnostics, therapy and prevention you will find background information on allerology.

Everything at a glance:

more than 380 allergens

vivid pictures for your consultations

simple operation

This year, the largest European congress for allergology and immunology, the EAACI, takes place in Warsaw, the capital of Poland. The congress organisers expect about 6.000 delegates. This is the first time that Allergopharma takes part as a Founder Sponsor...

From this year on Allergopharma has become Founder Sponsor to the European Association of Allergy and Clinical Immunology (EAACI). This is a logical step in the strategy to become a strong partner to the allergist and to communicate the engagement in the future of the speciality...

On March 1st 2009, a new allergy business unit was founded within Merck - Serono Spain, situated in Madrid, headed by Dr. Rosario Vivancos. Allergopharma is now prepared...

Italy: since April 1st 2008, Allergopharma is operating as an independent public company under the name Allergopharma S.p.A. Previously, the allergology business was conducted under the aegis of Merck S.p.A., the Italian subsidiary of Merck KGaA, Darmstadt, Germany.

On January 22, 2007, Heska Corporation, Colorado/USA, announced that it has completed the sale of its rights in a worldwide patent portfolio covering a number of major allergens and the genes that encode them to Allergopharma Joachim Ganzer KG for an undisclosed sum.